HK Stock Market Move | KINTOR PHARMA-B (09939) soared over 5%, with losses in the first half narrowing year-on-year, driven by a surge in income from cosmetics sales.

KINTOR PHARMA-B (09939) rose over 5%. As of the time of writing, it is up 5.56%, priced at HKD 1.71, with a transaction volume of HKD 3.6581 million. In news, the mid-term performance report for 2026 from Zai Lab shows that revenue increased from HKD 6 million in the same period last year to HKD 52 million for the six months ending June 30, 2026, with a net loss of HKD 75.782 million, a year-on-year decrease of 8.99%. The announcement stated that the revenue increase is mainly attributed to the sales of the new high-end cosmetics brand KOSHIN, driven by live e-commerce (with its main ingredient KX-826 being one of the company's core products). The decrease in net loss is primarily due to a reduction in research and development costs, partially offset by an increase in sales and marketing expenses mainly caused by higher marketing and promotional expenditures.